Last Posted: Dec 06, 2018
- Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers A Complex Discussion
S Domchek, JAMA< December 6, 2018 - A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults
M. Murray and the Genomics and Population Health Action Collaborative, National Academies of Medicine, December 3, 2018 - Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
Laitman Yael et al. Cancer 2018 Nov - Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey Melissa K et al. Cancer 2018 Nov - Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations.
Singer Christian F et al. European journal of cancer (Oxford, England : 1990) 2018 Nov 10654-60 - No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
Jacobson Michelle et al. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2018 Nov 40(11) 1497-1510 - Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
Xiao Ye-Lei et al. Clinical breast cancer 2018 Oct - A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico.
Diaz-Zabala Hector J et al. Cancers 2018 Nov 10(11) - Population Based Testing for Primary Prevention: A Systematic Review.
Manchanda Ranjit et al. Cancers 2018 Nov 10(11) - Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study ® .
Silver Michelle I et al. Breast cancer research and treatment 2018 Nov
.png)
No hay comentarios:
Publicar un comentario